Page last updated: 2024-12-09

4-dimethylaminostilbene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-dimethylaminostilbene: RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID640024
CHEMBL ID83880
SCHEMBL ID1557242
MeSH IDM0050685

Synonyms (53)

Synonym
CHEMBL83880
unii-1v7p79915n
1v7p79915n ,
4-12-00-03400 (beilstein handbook reference)
838-95-9
nsc30991
wln: 1n1&r d1u1r
benzenamine,n-dimethyl-4-(2-phenylethenyl)-
stilbenyl-n,n-dimethylamine
nsc-30991
4-stilbenamine,n-dimethyl-
4-dimethylaminostilbene
1145-73-9
4-dimethylaminostilben
IDI1_014233
benzenamine, n,n-dimethyl-4-[(e)-2-phenylethenyl]-
inchi=1/c16h17n/c1-17(2)16-12-10-15(11-13-16)9-8-14-6-4-3-5-7-14/h3-13h,1-2h3/b9-8
n,n-dimethyl-4-[(e)-2-phenylvinyl]aniline
SR-01000641230-1
4-stilbenamine, n,n-dimethyl-, (e)-
benzenamine, n,n-dimethyl-4-(2-phenylethenyl)-
trans-4-dimethylaminostilbene
4-stilbenamine, trans-n,n-dimethyl-
brn 2211373
benzenamine, n,n-dimethyl-4-(2-phenylethenyl)-, (e)-
ccris 988
trans-4-(dimethylamino)stilbene
trans-n,n-dimethyl-4-stilbenamine
trans-p-(dimethylamino)stilbene
D0255
4-(dimethylamino)stilbene
HMS1439B08
n,n-dimethyl-4-[(e)-2-phenylethenyl]aniline
CCG-51967
AKOS015850692
benzenamine, n,n-dimethyl-4-((1e)-2-phenylethenyl)-
bdbm150266
us8980954, 4cc
SCHEMBL1557242
n,n-dimethyl-4-[(e)-2-phenylethenyl]aniline #
4-dimethylamino-trans-stilbene
XGHHHPDRXLIMPM-CMDGGOBGSA-N
n,n-dimethyl-4-styrylaniline
mfcd00017151
AS-66960
4-stilbenamine,n,n-dimethyl-,e-
benzenamine, n,n-dimethyl-4-[(1e)-2-phenylethenyl]-
(e)-n,n-dimethyl-4-styrylaniline
BRD-K62258207-001-01-3
Q27252942
A894190
DTXSID401020720
(e)-4-dimethylaminostilbene

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Specific lesions of the stomach epithelium together with acute bone marrow incapacity and toxic effects on peripheral blood cells lead to acute anemia, which is considered to be the cause of death."( Tissue specific, acute toxic effects of the carcinogen trans-4-dimethylaminostilbene.
Marquardt, P; Neumann, HG; Romen, W, 1985
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Dose-response studies of the most active compounds were carried out to obtain IC50 values."( Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB.
Deck, LM; Gonzales, AM; Heynekamp, JJ; Hunsaker, LA; Jagt, DL; Orlando, RA; Weber, WM, 2006
)
0.33
" Among this panel, (E)-4-(2,6-difluorostyryl)-N,N-dimethylaniline (4r) inhibits Wnt signaling at nanomolar levels and inhibits the growth of human CRC cell xenografts in athymic nude mice at a dosage of 20 mg/kg."( Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.
Chen, X; Evers, BM; Kril, LM; Liu, C; Rychahou, P; Shi, J; Sviripa, V; Watt, DS; Yu, T; Zhang, W, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (17)

Assay IDTitleYearJournalArticle
AID168085Carcinogenic activity on liver after oral administration of the compound1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID168112Carcinogenic activity after oral administration1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID692960Inhibition of Wnt/beta-casein in human LS174T cells assessed as reduction in Axin-2 protein level at 10 uM by Western blotting2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.
AID273485Antioxidant activity measured as ability to reduce ferric tripyridyltriazine complex at 15 uM by FRAP assay2006Journal of medicinal chemistry, Nov-30, Volume: 49, Issue:24
Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB.
AID273486Inhibition of TNF-alpha-induced NF-kappaB activation in HEK293T cells2006Journal of medicinal chemistry, Nov-30, Volume: 49, Issue:24
Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB.
AID273490Suppression of LPS-stimulated COX2 mRNA expression in mouse BV2 cells at 0.15 uM2006Journal of medicinal chemistry, Nov-30, Volume: 49, Issue:24
Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB.
AID167955Carcinogenic activity on ear duct after oral administration1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID692957Inhibition of Wnt/beta-casein in human LS174T cells assessed as reduction in c-Myc protein level at 30 uM by Western blotting2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.
AID692959Inhibition of Wnt/beta-casein in human LS174T cells assessed as reduction in c-Myc protein level at 10 uM by Western blotting2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.
AID273484Antioxidant activity measured as ability to react with ABTS radical cation at 15 uM by TRAP assay2006Journal of medicinal chemistry, Nov-30, Volume: 49, Issue:24
Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB.
AID167927Carcinogenic activity on all sites after oral administration1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID167940Tested for carcinogenic activity on breast after oral administration of the compound; - denotes non carcinogenic activity.1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID660956Displacement of fluormone Pan-PPAR Green from mouse recombinant GST-tagged PPARbeta/delta LBD at 1 uM after 60 mins by TR-FRET assay2012Journal of medicinal chemistry, Mar-22, Volume: 55, Issue:6
(Z)-2-(2-bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}acrylonitrile (DG172): an orally bioavailable PPARβ/δ-selective ligand with inverse agonistic properties.
AID692958Inhibition of Wnt/beta-casein in human LS174T cells assessed as reduction in Axin-2 protein level at 30 uM by Western blotting2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.
AID692961Inhibition of Wnt/beta-casein in human LS174T cells assessed as effect on beta-casein protein level at 10 uM by Western blotting2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.
AID273487Loss in viability of human HEK293T cells at 15 uM after 7 hrs relative to control2006Journal of medicinal chemistry, Nov-30, Volume: 49, Issue:24
Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (79.17)18.7374
1990's1 (4.17)18.2507
2000's1 (4.17)29.6817
2010's3 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.55 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]